Mild Neurocognitive Disorder: Clinical Manifestations and Treatment
The decrease in fertility and the increase in the number of older people is a phenomenon that has never been observed before. This has brought with it an increase in chronic degenerative diseases, among which neurocognitive disorders stand out, particularly Mild Cognitive Impairment (MCI). This lead...
| Autor: | |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | México |
| Institución: | UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO |
| Repositorio: | Mexican Journal of Medical Research |
| Idioma: | inglés |
| OAI Identifier: | oai:repository.uaeh.edu.mx:article/12425 |
| Acceso en línea: | https://repository.uaeh.edu.mx/revistas/index.php/MJMR/article/view/12425 |
| Access Level: | acceso abierto |
| Palabra clave: | Mild cognitive impairment epidemiology treatment Deterioro cognitivo leve epidemiologia tratamiento |
| Sumario: | The decrease in fertility and the increase in the number of older people is a phenomenon that has never been observed before. This has brought with it an increase in chronic degenerative diseases, among which neurocognitive disorders stand out, particularly Mild Cognitive Impairment (MCI). This leads to deterioration in cognition and therefore a progression from mild to more severe levels such as major neurocognitive disorder (TNM). Although it is known that MCI is not synonymous with dementia, we must pay attention, since to a large extent people who suffer from mild cognitive impairment of amnestic time can develop Alzheimer's disease. That is why the purpose of the following article is to review and describe the epidemiology, risk factors, the main symptoms, as well as the treatments that have been developed for mild cognitive impairment such as pharmacological treatments, Cognitive Stimulation (CE). and Transcranial Direct Current Stimulation (tDCS). |
|---|